In PTEN null melanomas and in the human cell lines in our study, a key difference is significant AKT1 phosphorylation, which could compensate to drive tumor cell growth and survival, given the cellular sensitivity to AKT1 depletion in cell proliferation and tumor growth that we observed. This evidence concerns the gene PTEN and neoplasm.